Drug: |
MEK162 + BYL719 |
|||
---|---|---|---|---|
Trial: |
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
Massachusetts General Hospital100 Blossom St |
Principal Investigator: |
Dejan Juric, MD |
---|---|
Contact: |
Kathleen Kelly 617-724-0865 kbkelly@partners.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Massachusetts General Hospital Website: |
http://www.massgeneral.org/cancer/clinical_trials/adult/search_trials.asp |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.